{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:22:53Z","timestamp":1770060173867,"version":"3.49.0"},"reference-count":69,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Predominantly antibody deficiencies (PADs) are a heterogeneous group of primary immunodeficiency\ndisorders (PIDs), consisting of recurrent infections, autoimmunity, inflammation, and\nother immune complications. In the recent years, several immunological and genetic defects have been\nrecognized in PADs. Currently, 45 distinct PAD disorders with 40 different genetic defects have been\nidentified based on the 2019 IUIS classification. Genetic analysis is helpful for diagnosing PIDs; however,\ngenetic studies are expensive, time-consuming, and unavailable everywhere. Flow cytometry is a\nhighly sensitive tool for evaluating the immune system and diagnosing PADs. In addition to cell populations\nand subpopulations assay, flow cytometry can measure cell surface, intracellular and intranuclear\nproteins, biological changes associated with specific immune defects, and certain functional immune\nabnormalities. These capabilities help in rapid diagnostic and prognostic assessment as well as in\nevaluating the pathogenesis of PADs. For the first time, this review particularly provides an overview\nof the application of flow cytometry for diagnosis, immunophenotyping, and determining the pathogenesis\nof PADs.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871530320666200721013312","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T06:15:24Z","timestamp":1595398524000},"page":"647-663","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Application of Flow Cytometry in Predominantly Antibody Deficiencies"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5578-6595","authenticated-orcid":true,"given":"Reza","family":"Yazdani","sequence":"first","affiliation":[{"name":"Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Science, Tehran,Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9454-1603","authenticated-orcid":true,"given":"Asghar","family":"Aghamohammadi","sequence":"additional","affiliation":[{"name":"Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Science, Tehran,Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3836-1827","authenticated-orcid":true,"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[{"name":"Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Science, Tehran,Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"6","volume":"24","author":"Abolhassani H.","year":"2014","unstructured":"Abolhassani H.; Parvaneh N.; Rezaei N.; Hammarstrom L.; Aghamohammadi A.; Genetic defects in B-cell development and their clinical consequences. J Investig Allergol Clin Immunol 2014,24(1),6-22","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/ACI.0000000000000113","volume":"14","author":"Kindle G.","year":"2014","unstructured":"Kindle G.; Gathmann B.; Grimbacher B.; The use of databases in primary immunodeficiencies. Curr Opin Allergy Clin Immunol 2014,14(6),501-508","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/cei.12172","volume":"175","author":"Edgar J.D.","year":"2014","unstructured":"Edgar J.D.; Buckland M.; Guzman D.; Conlon N.P.; Knerr V.; Bangs C.; Reiser V.; Panahloo Z.; Workman S.; Slatter M.; Gennery A.R.; Davies E.G.; Allwood Z.; Arkwright P.D.; Helbert M.; Longhurst H.J.; Grigoriadou S.; Devlin L.A.; Huissoon A.; Krishna M.T.; Hackett S.; Kumararatne D.S.; Condliffe A.M.; Baxendale H.; Henderson K.; Bethune C.; Symons C.; Wood P.; Ford K.; Patel S.; Jain R.; Jolles S.; El-Shanawany T.; Alachkar H.; Herwadkar A.; Sargur R.; Shrimpton A.; Hayman G.; Abuzakouk M.; Spickett G.; Darroch C.J.; Paulus S.; Marshall S.E.; McDermott E.M.; Heath P.T.; Herriot R.; Noorani S.; Turner M.; Khan S.; Grimbacher B.; The United Kingdom primary immune deficiency (UKPID) registry: report of the first 4 years\u2019 activity 2008-2012. Clin Exp Immunol 2014,175(1),68-78","journal-title":"Clin Exp Immunol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/infdis\/154.3.422","volume":"154","author":"Arvin A.M.","year":"1986","unstructured":"Arvin A.M.; Koropchak C.M.; Williams B.R.; Grumet F.C.; Foung S.K.; Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J Infect Dis 1986,154(3),422-429","journal-title":"J Infect Dis"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1258\/acb.2008.008175","volume":"46","author":"Wood P.","year":"2009","unstructured":"Wood P.; Primary antibody deficiency syndromes. Ann Clin Biochem 2009,46(Pt 2),99-108","journal-title":"Ann Clin Biochem"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jaip.2018.09.004","volume":"7","author":"Yazdani R.","year":"2018","unstructured":"Yazdani R.; Abolhassani H.; Kiaee F.; Habibi S.; Azizi G.; Tavakol M.; Comparison of common monogenic defects in a large predominantly antibody deficiency cohort. J Allergy Clin Immunol Pract 2018,7(3),864-878.e9","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","volume":"40","author":"Tangye S.G.","year":"2020","unstructured":"Tangye S.G.; Al-Herz W.; Bousfiha A.; Chatila T.; Cunningham-Rundles C.; Etzioni A.; Franco J.L.; Holland S.M.; Klein C.; Morio T.; Ochs H.D.; Oksenhendler E.; Picard C.; Puck J.; Torgerson T.R.; Casanova J.L.; Sullivan K.E.; Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee. J Clin Immunol 2020,40(1),24-64","journal-title":"J Clin Immunol"},{"key":"ref=8","first-page":"1","volume":"263","author":"Givan A.L.","year":"2004","unstructured":"Givan A.L.; Flow cytometry: an introduction. Methods Mol Biol 2004,263,1-32","journal-title":"Methods Mol Biol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.iac.2008.06.003","volume":"28","author":"Yong P.F.","year":"2008","unstructured":"Yong P.F.; Chee R.; Grimbacher B.; Hypogammaglobulinaemia. Immunol Allergy Clin North Am ,vii.2008,28(4),691-713","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1440-1843.2009.01679.x","volume":"15","author":"Aghamohammadi A.","year":"2010","unstructured":"Aghamohammadi A.; Allahverdi A.; Abolhassani H.; Moazzami K.; Alizadeh H.; Gharagozlou M.; Kalantari N.; Sajedi V.; Shafiei A.; Parvaneh N.; Mohammadpour M.; Karimi N.; Sadaghiani M.S.; Rezaei N.; Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia. Respirology 2010,15(2),289-295","journal-title":"Respirology"},{"key":"ref=11","first-page":"610","volume":"96","author":"Nomura K.","year":"2000","unstructured":"Nomura K.; Kanegane H.; Karasuyama H.; Tsukada S.; Agematsu K.; Murakami G.; Sakazume S.; Sako M.; Tanaka R.; Kuniya Y.; Komeno T.; Ishihara S.; Hayashi K.; Kishimoto T.; Miyawaki T.; Genetic defect in human X-linked agammaglobulinemia impedes a maturational evolution of pro-B cells into a later stage of pre-B cells in the B-cell differentiation pathway. Blood 2000,96(2),610-617","journal-title":"Blood"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1046\/j.1365-2141.2001.02905.x","volume":"114","author":"Futatani T.","year":"2001","unstructured":"Futatani T.; Watanabe C.; Baba Y.; Tsukada S.; Ochs H.D.; Bruton\u2019s tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females. Br J Haematol 2001,114(1),141-149","journal-title":"Br J Haematol"},{"key":"ref=13","first-page":"595","volume":"91","author":"Futatani T.","year":"1998","unstructured":"Futatani T.; Miyawaki T.; Tsukada S.; Hashimoto S.; Kunikata T.; Arai S.; Kurimoto M.; Niida Y.; Matsuoka H.; Sakiyama Y.; Iwata T.; Tsuchiya S.; Tatsuzawa O.; Yoshizaki K.; Kishimoto T.; Deficient expression of Bruton\u2019s tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood 1998,91(2),595-602","journal-title":"Blood"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1067\/mai.2001.120133","volume":"108","author":"Kanegane H.","year":"2001","unstructured":"Kanegane H.; Futatani T.; Wang Y.; Nomura K.; Shinozaki K.; Matsukura H.; Kubota T.; Tsukada S.; Miyawaki T.; Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis. J Allergy Clin Immunol 2001,108(6),1012-1020","journal-title":"J Allergy Clin Immunol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1182\/blood.V88.2.561.bloodjournal882561","volume":"88","author":"Hashimoto S.","year":"1996","unstructured":"Hashimoto S.; Tsukada S.; Matsushita M.; Miyawaki T.; Niida Y.; Yachie A.; Kobayashi S.; Iwata T.; Hayakawa H.; Matsuoka H.; Tsuge I.; Yamadori T.; Kunikata T.; Arai S.; Yoshizaki K.; Taniguchi N.; Kishimoto T.; Identification of Bruton\u2019s tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan. Blood 1996,88(2),561-573","journal-title":"Blood"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1365-2249.2005.02784.x","volume":"140","author":"Kaneko H.","year":"2005","unstructured":"Kaneko H.; Kawamoto N.; Asano T.; Mabuchi Y.; Horikoshi H.; Teramoto T.; Matsui E.; Kondo M.; Fukao T.; Kasahara K.; Kondo N.; Leaky phenotype of X-linked agammaglobulinaemia in a Japanese family. Clin Exp Immunol 2005,140(3),520-523","journal-title":"Clin Exp Immunol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-2249.2008.03593.x","volume":"152","author":"Conley M.E.","year":"2008","unstructured":"Conley M.E.; Farmer D.M.; Dobbs A.K.; Howard V.; Aiba Y.; Shurtleff S.A.; Kurosaki T.; A minimally hypomorphic mutation in Btk resulting in reduced B cell numbers but no clinical disease. Clin Exp Immunol 2008,152(1),39-44","journal-title":"Clin Exp Immunol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1586\/1744666X.2016.1139451","volume":"12","author":"Abolhassani H.","year":"2016","unstructured":"Abolhassani H.; Vitali M.; Lougaris V.; Giliani S.; Parvaneh N.; Parvaneh L.; Mirminachi B.; Cheraghi T.; Khazaei H.; Mahdaviani S.A.; Kiaei F.; Tavakolinia N.; Mohammadi J.; Negahdari B.; Rezaei N.; Hammarstrom L.; Plebani A.; Aghamohammadi A.; Cohort of Iranian patients with congenital agammaglobulinemia: mutation analysis and novel gene defects. Expert Rev Clin Immunol 2016,12(4),479-486","journal-title":"Expert Rev Clin Immunol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1084\/jem.20112533","volume":"209","author":"Conley M.E.","year":"2012","unstructured":"Conley M.E.; Dobbs A.K.; Quintana A.M.; Bosompem A.; Wang Y.D.; Coustan-Smith E.; Smith A.M.; Perez E.E.; Murray P.J.; Agammaglobulinemia and absent B lineage cells in a patient lacking the p85\u03b1 subunit of PI3K. J Exp Med 2012,209(3),463-470","journal-title":"J Exp Med"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s10875-017-0462-y","volume":"38","author":"Tang P.","year":"2018","unstructured":"Tang P.; Upton J.E.M.; Barton-Forbes M.A.; Salvadori M.I.; Clynick M.P.; Price A.K.; Goobie S.L.; Autosomal recessive agammaglobulinemia due to a homozygous mutation in PIK3R1. J Clin Immunol 2018,38(1),88-95","journal-title":"J Clin Immunol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.18176\/jiaci.0388","volume":"30","author":"Yazdani R.","year":"2019","unstructured":"Yazdani R.; Habibi S.; Sharifi L.; Azizi G.; Abolhassani H.; Olbrich P.; Common variable immunodeficiency: epidemiology, pathogenesis, clinical manifestations, diagnosis, classification and management. J Investig Allergol Clin Immunol 2019,30(1),14-34","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1749-6632.2011.06338.x","volume":"1246","author":"Park J.H.","year":"2011","unstructured":"Park J.H.; Resnick E.S.; Cunningham-Rundles C.; Perspectives on common variable immune deficiency. Ann N Y Acad Sci 2011,1246(1),41-49","journal-title":"Ann N Y Acad Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/cyto.b.20432","volume":"74","author":"Warnatz K.","year":"2008","unstructured":"Warnatz K.; Schlesier M.; Flowcytometric phenotyping of common variable immunodeficiency. Cytometry B Clin Cytom 2008,74(5),261-271","journal-title":"Cytometry B Clin Cytom"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","volume":"99","author":"Warnatz K.","year":"2002","unstructured":"Warnatz K.; Denz A.; Dr\u00e4ger R.; Braun M.; Groth C.; Wolff-Vorbeck G.; Eibel H.; Schlesier M.; Peter H.H.; Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002,99(5),1544-1551","journal-title":"Blood"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1023\/A:1025373601374","volume":"23","author":"Piqueras B.","year":"2003","unstructured":"Piqueras B.; Lavenu-Bombled C.; Galicier L.; Bergeron-van der Cruyssen F.; Mouthon L.; Chevret S.; Debr\u00e9 P.; Schmitt C.; Oksenhendler E.; Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 2003,23(5),385-400","journal-title":"J Clin Immunol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","volume":"111","author":"Wehr C.","year":"2008","unstructured":"Wehr C.; Kivioja T.; Schmitt C.; Ferry B.; Witte T.; Eren E.; Vlkova M.; Hernandez M.; Detkova D.; Bos P.R.; Poerksen G.; von Bernuth H.; Baumann U.; Goldacker S.; Gutenberger S.; Schlesier M.; Bergeron-van der Cruyssen F.; Le Garff M.; Debr\u00e9 P.; Jacobs R.; Jones J.; Bateman E.; Litzman J.; van Hagen P.M.; Plebani A.; Schmidt R.E.; Thon V.; Quinti I.; Espanol T.; Webster A.D.; Chapel H.; Vihinen M.; Oksenhendler E.; Peter H.H.; Warnatz K.; The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008,111(1),77-85","journal-title":"Blood"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"6814","DOI":"10.1182\/blood-2011-06-361881","volume":"118","author":"Driessen G.J.","year":"2011","unstructured":"Driessen G.J.; van Zelm M.C.; van Hagen P.M.; Hartwig N.G.; Trip M.; Warris A.; de Vries E.; Barendregt B.H.; Pico I.; Hop W.; van Dongen J.J.; van der Burg M.; B-cell replication history and somatic hypermutation status identify distinct pathophysiologic backgrounds in common variable immunodeficiency. Blood 2011,118(26),6814-6823","journal-title":"Blood"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.aller.2016.07.001","volume":"45","author":"Yazdani R.","year":"2017","unstructured":"Yazdani R.; Seify R.; Ganjalikhani-Hakemi M.; Abolhassani H.; Eskandari N.; Golsaz-Shirazi F.; Ansaripour B.; Salehi E.; Azizi G.; Rezaei N.; Aghamohammadi A.; Comparison of various classifications for patients with common variable immunodeficiency (CVID) using measurement of B-cell subsets. Allergol Immunopathol (Madr) 2017,45(2),183-192","journal-title":"Allergol Immunopathol (Madr)"},{"key":"ref=29","first-page":"321","volume":"17","author":"Vodjgani M.","year":"2007","unstructured":"Vodjgani M.; Aghamohammadi A.; Samadi M.; Moin M.; Hadjati J.; Mirahmadian M.; Parvaneh N.; Salavati A.; Abdollahzade S.; Rezaei N.; Srrafnejad A.; Analysis of class-switched memory B cells in patients with common variable immunodeficiency and its clinical implications. J Investig Allergol Clin Immunol 2007,17(5),321-328","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1080\/00313020801911470","volume":"40","author":"Berglund L.J.","year":"2008","unstructured":"Berglund L.J.; Wong S.W.; Fulcher D.A.; B-cell maturation defects in common variable immunodeficiency and association with clinical features. Pathology 2008,40(3),288-294","journal-title":"Pathology"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s10875-010-9424-3","volume":"30","author":"Mouillot G.","year":"2010","unstructured":"Mouillot G.; Carmagnat M.; G\u00e9rard L.; Garnier J.L.; Fieschi C.; Vince N.; Karlin L.; Viallard J.F.; Jaussaud R.; Boileau J.; Donadieu J.; Gardembas M.; Schleinitz N.; Suarez F.; Hachulla E.; Delavigne K.; Morisset M.; Jacquot S.; Just N.; Galicier L.; Charron D.; Debr\u00e9 P.; Oksenhendler E.; Rabian C.; B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease. J Clin Immunol DEFI study group2010,30(5),746-755","journal-title":"J Clin Immunol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1365-2249.2011.04507.x","volume":"167","author":"Al Kindi M.","year":"2012","unstructured":"Al Kindi M.; Mundy J.; Sullivan T.; Smith W.; Kette F.; Smith A.; Heddle R.; Hissaria P.; Utility of peripheral blood B cell subsets analysis in common variable immunodeficiency. Clin Exp Immunol 2012,167(2),275-281","journal-title":"Clin Exp Immunol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molimm.2015.12.016","volume":"71","author":"Yazdani R.","year":"2016","unstructured":"Yazdani R.; Fatholahi M.; Ganjalikhani-Hakemi M.; Abolhassani H.; Azizi G.; Hamid K.M.; Rezaei N.; Aghamohammadi A.; Role of apoptosis in common variable immunodeficiency and selective immunoglobulin A deficiency. Mol Immunol 2016,71,1-9","journal-title":"Mol Immunol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2174\/1871530317666170919120245","volume":"17","author":"Ganjalikhani-Hakemi M.","year":"2017","unstructured":"Ganjalikhani-Hakemi M.; Yazdani R.; Esmaeili M.; Abolhassani H.; Rae W.; Azizi G.; Dizaji M.Z.; Shaghaghi M.; Rezaei A.; Abbasi-Rad F.; Afshar-Qasemloo S.; Mohammadi S.; Rezaei N.; Aghamohammadi A.; Role of apoptosis in the pathogenesis of common variable immunodeficiency (CVID). Endocr Metab Immune Disord Drug Targets 2017,17(4),332-340","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.18176\/jiaci.0069","volume":"26","author":"Azizi G.","year":"2016","unstructured":"Azizi G.; Rezaei N.; Kiaee F.; Tavakolinia N.; Yazdani R.; Mirshafiey A.; Aghamohammadi A.; T-Cell abnormalities in common variable immunodeficiency. J Investig Allergol Clin Immunol 2016,26(4),233-243","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1365-2249.2012.04643.x","volume":"170","author":"Bateman E.A.","year":"2012","unstructured":"Bateman E.A.; Ayers L.; Sadler R.; Lucas M.; Roberts C.; Woods A.; Packwood K.; Burden J.; Harrison D.; Kaenzig N.; Lee M.; Chapel H.M.; Ferry B.L.; T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections. Clin Exp Immunol 2012,170(2),202-211","journal-title":"Clin Exp Immunol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1086\/606059","volume":"49","author":"Malphettes M.","year":"2009","unstructured":"Malphettes M.; G\u00e9rard L.; Carmagnat M.; Mouillot G.; Vince N.; Boutboul D.; B\u00e9rezn\u00e9 A.; Nove-Josserand R.; Lemoing V.; Tetu L.; Viallard J.F.; Bonnotte B.; Pavic M.; Haroche J.; Larroche C.; Brouet J.C.; Fermand J.P.; Rabian C.; Fieschi C.; Oksenhendler E.; Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis DEFI study group2009,49(9),1329-1338","journal-title":"Clin Infect Dis"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1126\/science.1373518","volume":"256","author":"Carter R.H.","year":"1992","unstructured":"Carter R.H.; Fearon D.T.; CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992,256(5053),105-107","journal-title":"Science"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/sj.gene.6364431","volume":"8","author":"Kanegane H.","year":"2007","unstructured":"Kanegane H.; Agematsu K.; Futatani T.; Sira M.M.; Suga K.; Sekiguchi T.; van Zelm M.C.; Miyawaki T.; Novel mutations in a Japanese patient with CD19 deficiency. Genes Immun 2007,8(8),663-670","journal-title":"Genes Immun"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1056\/NEJMoa051568","volume":"354","author":"van Zelm M.C.","year":"2006","unstructured":"van Zelm M.C.; Reisli I.; van der Burg M.; Casta\u00f1o D.; van Noesel C.J.; van Tol M.J.; Woellner C.; Grimbacher B.; Pati\u00f1o P.J.; van Dongen J.J.; Franco J.L.; An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 2006,354(18),1901-1912","journal-title":"N Engl J Med"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1172\/JCI39748","volume":"120","author":"van Zelm M.C.","year":"2010","unstructured":"van Zelm M.C.; Smet J.; Adams B.; Mascart F.; Schanden\u00e9 L.; Janssen F.; Ferster A.; Kuo C.C.; Levy S.; van Dongen J.J.; van der Burg M.; CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Invest 2010,120(4),1265-1274","journal-title":"J Clin Invest"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jaci.2013.11.015","volume":"134","author":"van Zelm M.C.","year":"2014","unstructured":"van Zelm M.C.; Bartol S.J.; Driessen G.J.; Mascart F.; Reisli I.; Franco J.L.; Wolska-Kusnierz B.; Kanegane H.; Boon L.; van Dongen J.J.; van der Burg M.; Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation. J Allergy Clin Immunol 2014,134(1),135-144","journal-title":"J Allergy Clin Immunol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1093\/hmg\/ddr068","volume":"20","author":"van Zelm M.C.","year":"2011","unstructured":"van Zelm M.C.; Smet J.; van der Burg M.; Ferster A.; Le P.Q.; Schanden\u00e9 L.; van Dongen J.J.; Mascart F.; Antibody deficiency due to a missense mutation in CD19 demonstrates the importance of the conserved tryptophan 41 in immunoglobulin superfamily domain formation. Hum Mol Genet 2011,20(9),1854-1863","journal-title":"Hum Mol Genet"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000075685","volume":"7","author":"Carter R.H.","year":"2004","unstructured":"Carter R.H.; Barrington R.A.; Signaling by the CD19\/CD21 complex on B cells. Curr Dir Autoimmun 2004,7,4-32","journal-title":"Curr Dir Autoimmun"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.jaci.2011.09.027","volume":"129","author":"Thiel J.","year":"2012","unstructured":"Thiel J.; Kimmig L.; Salzer U.; Grudzien M.; Lebrecht D.; Hagena T.; Draeger R.; Voelxen N.; Bergbreiter A.; Jennings S.; Gutenberger S.; Aichem A.; Illges H.; Hannan J.P.; Kienzler A.K.; Rizzi M.; Eibel H.; Peter H.H.; Warnatz K.; Grimbacher B.; Rump J.A.; Schlesier M.; Genetic CD21 deficiency is associated with hypogammaglobulinemia. J Allergy Clin Immunol 2012,129(3),801-810.e6","journal-title":"J Allergy Clin Immunol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.clim.2015.08.010","volume":"161","author":"Wentink M.W.","year":"2015","unstructured":"Wentink M.W.; Lambeck A.J.; van Zelm M.C.; Simons E.; van Dongen J.J.; IJspeert H.; Sch\u00f6lvinck E.H.; van der Burg M.; CD21 and CD19 deficiency: two defects in the same complex leading to different disease modalities. Clin Immunol 2015,161(2),120-127","journal-title":"Clin Immunol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.jaip.2017.04.011","volume":"5","author":"Rosain J.","year":"2017","unstructured":"Rosain J.; Miot C.; Lambert N.; Rousselet M.C.; Pellier I.; Picard C.; CD21 deficiency in 2 siblings with recurrent respiratory infections and hypogammaglobulinemia. J Allergy Clin Immunol Pract 2017,5(6),1765-1767.e3","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/intimm\/14.5.513","volume":"14","author":"Deng J.","year":"2002","unstructured":"Deng J.; Dekruyff R.H.; Freeman G.J.; Umetsu D.T.; Levy S.; Critical role of CD81 in cognate T-B cell interactions leading to Th2 responses. Int Immunol 2002,14(5),513-523","journal-title":"Int Immunol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/intimm\/dxh009","volume":"16","author":"Uchida J.","year":"2004","unstructured":"Uchida J.; Lee Y.; Hasegawa M.; Liang Y.; Bradney A.; Oliver J.A.; Bowen K.; Steeber D.A.; Haas K.M.; Poe J.C.; Tedder T.F.; Mouse CD20 expression and function. Int Immunol 2004,16(1),119-129","journal-title":"Int Immunol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"14733","DOI":"10.1074\/jbc.272.23.14733","volume":"272","author":"Kanzaki M.","year":"1997","unstructured":"Kanzaki M.; Lindorfer M.A.; Garrison J.C.; Kojima I.; Activation of the calcium-permeable cation channel CD20 by alpha subunits of the Gi protein. J Biol Chem 1997,272(23),14733-14739","journal-title":"J Biol Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1172\/JCI40231","volume":"120","author":"Kuijpers T.W.","year":"2010","unstructured":"Kuijpers T.W.; Bende R.J.; Baars P.A.; Grummels A.; Derks I.A.; Dolman K.M.; Beaumont T.; Tedder T.F.; van Noesel C.J.; Eldering E.; van Lier R.A.; CD20 deficiency in humans results in impaired T cell-independent antibody responses. J Clin Invest 2010,120(1),214-222","journal-title":"J Clin Invest"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/ng1601","volume":"37","author":"Castigli E.","year":"2005","unstructured":"Castigli E.; Wilson S.A.; Garibyan L.; Rachid R.; Bonilla F.; Schneider L.; Geha R.S.; TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005,37(8),829-834","journal-title":"Nat Genet"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/ng0407-430","volume":"39","author":"Castigli E.","year":"2007","unstructured":"Castigli E.; Wilson S.; Garibyan L.; Rachid R.; Bonilla F.; Schneider L.; Morra M.; Curran J.; Geha R.; Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 2007,39(4),430-431","journal-title":"Nat Genet"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s12016-014-8412-4","volume":"46","author":"Locke B.A.","year":"2014","unstructured":"Locke B.A.; Dasu T.; Verbsky J.W.; Laboratory diagnosis of primary immunodeficiencies. Clin Rev Allergy Immunol 2014,46(2),154-168","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1182\/blood-2008-02-141937","volume":"113","author":"Salzer U.","year":"2009","unstructured":"Salzer U.; Bacchelli C.; Buckridge S.; Pan-Hammarstr\u00f6m Q.; Jennings S.; Lougaris V.; Bergbreiter A.; Hagena T.; Birmelin J.; Plebani A.; Webster A.D.; Peter H.H.; Suez D.; Chapel H.; McLean-Tooke A.; Spickett G.P.; Anover-Sombke S.; Ochs H.D.; Urschel S.; Belohradsky B.H.; Ugrinovic S.; Kumararatne D.S.; Lawrence T.C.; Holm A.M.; Franco J.L.; Schulze I.; Schneider P.; Gertz E.M.; Sch\u00e4ffer A.A.; Hammarstr\u00f6m L.; Thrasher A.J.; Gaspar H.B.; Grimbacher B.; Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood 2009,113(9),1967-1976","journal-title":"Blood"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.4049\/jimmunol.180.6.3655","volume":"180","author":"Benson M.J.","year":"2008","unstructured":"Benson M.J.; Dillon S.R.; Castigli E.; Geha R.S.; Xu S.; Lam, KP Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL. J Immunol 2008,180(6),3655-3659","journal-title":"J Immunol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.smim.2006.04.006","volume":"18","author":"Bossen C.","year":"2006","unstructured":"Bossen C.; Schneider P.; BAFF, APRIL and their receptors: structure, function and signaling. Semin Immunol 2006,18(5),263-275","journal-title":"Semin Immunol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"13945","DOI":"10.1073\/pnas.0903543106","volume":"106","author":"Warnatz K.","year":"2009","unstructured":"Warnatz K.; Salzer U.; Rizzi M.; Fischer B.; Gutenberger S.; B\u00f6hm J.; Kienzler A.K.; Pan-Hammarstr\u00f6m Q.; Hammarstr\u00f6m L.; Rakhmanov M.; Schlesier M.; Grimbacher B.; Peter H.H.; Eibel H.; B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci USA 2009,106(33),13945-13950","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fimmu.2018.00369","volume":"9","author":"Michalovich D.","year":"2018","unstructured":"Michalovich D.; Nejentsev S.; Activated PI3 kinase delta syndrome: from genetics to therapy. Front Immunol 2018,9,369","journal-title":"Front Immunol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jaci.2016.03.022","volume":"138","author":"Elkaim E.","year":"2016","unstructured":"Elkaim E.; Neven B.; Bruneau J.; Mitsui-Sekinaka K.; Stanislas A.; Heurtier L.; Lucas C.L.; Matthews H.; Deau M.C.; Sharapova S.; Curtis J.; Reichenbach J.; Glastre C.; Parry D.A.; Arumugakani G.; McDermott E.; Kilic S.S.; Yamashita M.; Moshous D.; Lamrini H.; Otremba B.; Gennery A.; Coulter T.; Quinti I.; Stephan J.L.; Lougaris V.; Brodszki N.; Barlogis V.; Asano T.; Galicier L.; Boutboul D.; Nonoyama S.; Cant A.; Imai K.; Picard C.; Nejentsev S.; Molina T.J.; Lenardo M.; Savic S.; Cavazzana M.; Fischer A.; Durandy A.; Kracker S.; Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase \u03b4 syndrome 2: a cohort study. J Allergy Clin Immunol 2016,138(1),210-218.e9","journal-title":"J Allergy Clin Immunol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3389\/fimmu.2018.00543","volume":"9","author":"Maccari M.E.","year":"2018","unstructured":"Maccari M.E.; Abolhassani H.; Aghamohammadi A.; Aiuti A.; Aleinikova O.; Bangs C.; Baris S.; Barzaghi F.; Baxendale H.; Buckland M.; Burns S.O.; Cancrini C.; Cant A.; Cath\u00e9bras P.; Cavazzana M.; Chandra A.; Conti F.; Coulter T.; Devlin L.A.; Edgar J.D.M.; Faust S.; Fischer A.; Garcia-Prat M.; Hammarstr\u00f6m L.; Heeg M.; Jolles S.; Karakoc-Aydiner E.; Kindle G.; Kiykim A.; Kumararatne D.; Grimbacher B.; Longhurst H.; Mahlaoui N.; Milota T.; Moreira F.; Moshous D.; Mukhina A.; Neth O.; Neven B.; Nieters A.; Olbrich P.; Ozen A.; Pachlopnik Schmid J.; Picard C.; Prader S.; Rae W.; Reichenbach J.; Rusch S.; Savic S.; Scarselli A.; Scheible R.; Sediva A.; Sharapova S.O.; Shcherbina A.; Slatter M.; Soler-Palacin P.; Stanislas A.; Suarez F.; Tucci F.; Uhlmann A.; van Montfrans J.; Warnatz K.; Williams A.P.; Wood P.; Kracker S.; Condliffe A.M.; Ehl S.; Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase \u03b4 syndrome: the European society for immunodeficiencies-activated phosphoinositide 3-kinase \u03b4 syndrome registry. Front Immunol 2018,9(543),543","journal-title":"Front Immunol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","volume":"139","author":"Coulter T.I.","year":"2017","unstructured":"Coulter T.I.; Chandra A.; Bacon C.M.; Babar J.; Curtis J.; Screaton N.; Goodlad J.R.; Farmer G.; Steele C.L.; Leahy T.R.; Doffinger R.; Baxendale H.; Bernatoniene J.; Edgar J.D.; Longhurst H.J.; Ehl S.; Speckmann C.; Grimbacher B.; Sediva A.; Milota T.; Faust S.N.; Williams A.P.; Hayman G.; Kucuk Z.Y.; Hague R.; French P.; Brooker R.; Forsyth P.; Herriot R.; Cancrini C.; Palma P.; Ariganello P.; Conlon N.; Feighery C.; Gavin P.J.; Jones A.; Imai K.; Ibrahim M.A.; Markelj G.; Abinun M.; Rieux-Laucat F.; Latour S.; Pellier I.; Fischer A.; Touzot F.; Casanova J.L.; Durandy A.; Burns S.O.; Savic S.; Kumararatne D.S.; Moshous D.; Kracker S.; Vanhaesebroeck B.; Okkenhaug K.; Picard C.; Nejentsev S.; Condliffe A.M.; Cant A.J.; Clinical spectrum and features of activated phosphoinositide 3-kinase \u03b4 syndrome: a large patient cohort study. J Allergy Clin Immunol 2017,139(2),597-606.e4","journal-title":"J Allergy Clin Immunol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.clim.2015.04.014","volume":"159","author":"Lougaris V.","year":"2015","unstructured":"Lougaris V.; Faletra F.; Lanzi G.; Vozzi D.; Marcuzzi A.; Valencic E.; Piscianz E.; Bianco A.; Girardelli M.; Baronio M.; Loganes C.; Fasth A.; Salvini F.; Trizzino A.; Moratto D.; Facchetti F.; Giliani S.; Plebani A.; Tommasini A.; Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype. Clin Immunol 2015,159(1),33-36","journal-title":"Clin Immunol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.clim.2016.01.016","volume":"164","author":"Di Fonte R.","year":"2016","unstructured":"Di Fonte R.; Baronio M.; Plebani A.; Lougaris V.; Fousteri G.; Reduced germinal center follicular helper T cells but normal follicular regulatory T cells in the tonsils of a patient with a mutation in the PI3KR1 gene. Clin Immunol 2016,164,43-44","journal-title":"Clin Immunol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3389\/fimmu.2018.00568","volume":"9","author":"Asano T.","year":"2018","unstructured":"Asano T.; Okada S.; Tsumura M.; Yeh T.W.; Mitsui-Sekinaka K.; Tsujita Y.; Ichinose Y.; Shimada A.; Hashimoto K.; Wada T.; Imai K.; Ohara O.; Morio T.; Nonoyama S.; Kobayashi M.; Enhanced AKT phosphorylation of circulating B cells in patients with activated PI3K\u03b4 syndrome. Front Immunol 2018,9(568),568","journal-title":"Front Immunol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/sji.12499","volume":"85","author":"Yazdani R.","year":"2017","unstructured":"Yazdani R.; Azizi G.; Abolhassani H.; Aghamohammadi A.; Selective IgA deficiency: epidemiology, pathogenesis, clinical phenotype, diagnosis, prognosis and management. Scand J Immunol 2017,85(1),3-12","journal-title":"Scand J Immunol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1159\/000323903","volume":"156","author":"Aghamohammadi A.","year":"2011","unstructured":"Aghamohammadi A.; Abolhassani H.; Biglari M.; Abolmaali S.; Moazzami K.; Tabatabaeiyan M.; Asgarian-Omran H.; Parvaneh N.; Mirahmadian M.; Rezaei N.; Analysis of switched memory B cells in patients with IgA deficiency. Int Arch Allergy Immunol 2011,156(4),462-468","journal-title":"Int Arch Allergy Immunol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10875-012-9655-6","volume":"32","author":"Nechvatalova J.","year":"2012","unstructured":"Nechvatalova J.; Pikulova Z.; Stikarovska D.; Pesak S.; Vlkova M.; Litzman J.; B-lymphocyte subpopulations in patients with selective IgA deficiency. J Clin Immunol 2012,32(3),441-448","journal-title":"J Clin Immunol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000339867","volume":"160","author":"Soheili H.","year":"2013","unstructured":"Soheili H.; Abolhassani H.; Arandi N.; Khazaei H.A.; Shahinpour S.; Hirbod-Mobarakeh A.; Rezaei N.; Aghamohammadi A.; Evaluation of natural regulatory T cells in subjects with selective IgA deficiency: from senior idea to novel opportunities. Int Arch Allergy Immunol 2013,160(2),208-214","journal-title":"Int Arch Allergy Immunol"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/183978","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/183978\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/183978","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T06:43:26Z","timestamp":1648449806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/183978\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530320666200721013312","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-02-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}